Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects.

ABSTRACT:

Aim

The coronavirus disease (COVID)-19 incidence was higher in diabetes mellitus (DM), although several differences should be considered on the basis of characteristics of cohorts evaluated. This study was designed to evaluate the prevalence and potential consequences of COVID-19 in a large diabetic population in Northern Italy.

Design

Observational, longitudinal, retrospective, clinical study.

Methods

Subjects with both type 1 and type 2 DM living in the Province of Modena and submitted to at least one SARS-CoV-2 swab between March 2020 and March 2021 were included. Data were extracted from the Hospital data warehouse.

Results

9553 diabetic subjects were enrolled (age 68.8 ± 14.1 years, diabetes duration 11.0 ± 6.9 years, glycated hemoglobin 57.2 ± 16.2 mmol/m

SUBMITTER: Greco C 

PROVIDER: S-EPMC10025792 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature